Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43

Medical Physics

Volumn 22, Issue 2, 1995, Pages 209-234

  Nath, Ravinder ^a   Anderson, Lowell L ^b   Luxton, Gary ^c   Weaver, Keith A ^d   Williamson, Jeffey F ^e   Meigooni, Ali S ^f  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISOTROPY; BRACHYTHERAPY; DOSE CALCULATION; DOSIMETRY; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION ATTENUATION; REVIEW;

BRACHYTHERAPY; HUMAN; IODINE RADIOISOTOPES; IRIDIUM RADIOISOTOPES; MATHEMATICS; MODELS, THEORETICAL; PALLADIUM; RADIOISOTOPES; RADIOTHERAPY DOSAGE;

EID: 0028919251     PISSN: 00942405     EISSN: NA     Source Type: Journal    
DOI: 10.1118/1.597458     Document Type: Article

References (80)

1. Interstitial Collaborative Working Group (ICWG) Interstitial Brachy-therapy: Physical, Biological, and Clinical Considerations, edited by L. L. Anderson, R. Nath, and K. A. Weaver (Raven, New York, 1990).
2. M. B. Podgorsak, L. A. DeWerd, and B. R. Paliwal, “The half life of high dose rate Ir-192 sources,” Med. Phys. 20, 1257–1259 (1993).
3. G. P. Glasgow and L. T. Dillman, “Specific-ray constant and exposure rate constant for Ir,” Med. Phys. 6, 49–52 (1979).
4. T. Altzitzoglou, “The half life of I,” Appl. Radiat. Isot. 42, 493–494 (1991).
5. T. P. Loftus, “Exposure standardization of l25I seeds used for brachy-therapy,” J. Res. Natl. Bur. Stand. 89, 295–303 (1984).
6. C. C. Ling, M. C. Schell, E. D. Yorke, B. B. Palos, and D. O. Kubiatow-icz, “Two-dimensional dose distribution of I seeds,” Med. Phys. 12, 652–655 (1985).
7. M. C. Schell, C. C. Ling, Z. C. Gromadzki, and K. R. Working, “Dose distribution of model 6702 I seeds in water,” Int. J. Radiat. Oncol. Biol. Phys. 13, 795–799 (1987).
8. K. A. Weaver, V. Smith, D. Huang, C. Barnett, M. C. Schell, and C. C. Ling, “Dose parameters of I and Ir seed sources,” Med. Phys. 16, 636–643 (1989).
9. R. Nath, A. S. Meigooni, and J. A. Meli, “Dosimetry on the transverse axis of l25I and 192Ir interstitial brachytherapy sources,” Med. Phys. 17, 1032–1040 (1990).
10. S.-T. Chiu-Tsao, L. L. Anderson, K. O’Brien, and R. Sanna, “Dose rate determination for, I seeds,” Med. Phys. 17, 815–825 (1990).
11. E. Browne and R. B. Firestone, Table of Isotopes (Wiley, New York, 1986).
12. A. S. Meigooni, S. Sabnis, and R. Nath, “Dosimetry of 103Pd brachy-therapy sources for permanent implant,” Endocurietherapy Hypertherm. Oncol. 6, 107–117 (1990).
13. AAPM Report No. 21, Recommendations of AAPM Task Group 32: Specification of Brachytherapy Source Strength (American Institute ol Physics, New York, 1987).
14. J. F. Williamson and R. Nath, “Clinical implementation of AAPM Task Group 32 recommendations on brachytherapy source strength specification,” Med. Phys. 18, 439–448 (1991).
15. R. G. Dale, “A Monte Carlo derivation of parameters for use in the tissue dosimetry of medium and low energy nuclides,” Br. J. Radiol. 55, 748–757 (1982).
16. R. G. Dale, “Some theoretical derivations relating to the tissue dosimetry of brachytherapy nuclides, with particular reference to 125I,” Med. Phys. 10, 176–183 (1983).
17. R. G. Dale, “Revisions to radial dose function data for I and l37Cs,” letter to Med. Phys. 13, 963–964 (1986).
18. J. F. Williamson, “Comparison of measured and calculated dose rates in water near 1–125 and Ir-192 seeds,” Med. Phys. 18, 776 (1991).
19. S.-T. Chiu-Tsao and L. L. Anderson, “Thermoluminiscent dosimetry for Pd (Model 200) in solid water phantom,” Med. Phys. 18, 449–452 (1991).
20. R. Nath, A. S. Meigooni, P. Muench, and A. Melillo, “Anisotropy functions for l03Pd, I, and l92Ir interstitial brachytherapy sources,” Med. Phys. 20, 1465–1473 (1993).
21. M. Boutillon and A. M. Perroche-Roux, “Reevaiuation of the W value for electrons in dry air,” Phys. Med. Biol. 32, 2134 (1987).
22. F. H. Attix and V. H. Ritz, “A determination of the gamma-ray emission of radium,” J. Res. Natl. Bur. Stand. 59, 293–305 (1957).
23. M. J. Berger, “Energy deposition in water by photons from point isotropic sources,” MIRD pamphlet No. 2, J. Nucl. Med. Suppl. No. 1, 15–25 (1968).
24. G. S. Burns and D. E. Raeside, “Monte Carlo simulation on the dose distribution around a commercial 125I seed,” Med. Phys. 15, 56–60 (1988).
25. L. L. Meisberger, R. Keller and, R. J. Shalek, “The effective attenuation in water of the gamma rays of Au, 1921, Cs, Ra, and Co,” Radiology 90, 953–957 (1968).
26. A. S. Meigooni, J. A. Meli, and R. Nath, “A comparison of solid phantoms with water for dosimetry of 125I brachytherapy sources,” Med. Phys. 15, 695–701 (1988).
27. J. F. Williamson and F. J. Quintero, “Theoretical evaluation of dose distributions in water about models 6711 and 6702 I seeds,” Med. Phys. 15, 891–897 (1988).
28. J. F. Williamson, “Monte Carlo and analytic calculation of absorbed dose near Cs intracavitary sources,” Int. J. Radiat. Oncol. Biol. Phys. 15, 227 (1988).
29. B. L. Diffey and S. C. Klevenhagen, “An experimental and calculated dose distribution in water around CDC K-type l37Cs sources,” Phys. Med. Biol. 20, 446 (1975).
30. F. J. Larke, “A practical improvement to the Sievert integral for more accurate dose distributions about iodine-125 brachytherapy seeds,” M. S. thesis, the University of Colorado Health Sciences Center, Denver, CO, April, 1991.
31. W. J. Meredith, D. Greene, and K. Kawashima, “The attenuation and scattering phantom of gamma rays from some radionuclides used in mould and interstitial gamma-ray therapy,” Br. J. Radiol. 39, 280–286 (1966).
32. G. P. Glasgow, “Exposure rate constants for filtered Ir sources,” Med. Phys. 8, 502–503 (1981).
33. S. Webb and R. A. Fox, “The dose in water surrounding point isotropic gamma-ray emitters,” Br. J. Radiol. 52, 482–484 (1979).
34. R. O. Komelsen and M. E. J. Young, “Brachytherapy buildup factors,” Br. J. Radiol. 54, 136 (1981).
35. A. L. Boyer, P. D. Cobb, K. R. Kase, and D. T. S. Chiu, “Ir-192 hospital calibration procedures,” in Recent Advances in Brachytherapy Physics, edited by D. A. Shearer, AAPM Monograph 7 (American Institute of Physics, New York, 1981), pp. 82–103.
36. T. P. Loftus, “Standardization of Ir gamma ray sources in terms of exposure,” J. Res. Natl. Bur. Stand. 85, 19–25 (1980).
37. W. P. M. Mayles and P. C. R. Turner, “The calculation of Ir parameters for use in tissue dosimetry,” letter to Br. J. Radiol. 56, 606 (1983).
38. A. D. Welsh, A. Dixon-Brown, and J. B. H. Stedford. “Calculation of dose distributions for, Ir implants,” Acta Radiol. Oncol. 22. 331–336 1983).
39. I. F. Williamson, R. L. Morin, and F. M. Khan, “Monte Carlo evaluation of Sievert integral for brachytherapy dosimetry,” Phys. Med. Biol. 28, 1021–1032 (1983).
40. C. C. Ling, Z. C. Gromadzki, S. N. Rustgi, and J. H. Cundiff, “Directional dependence of radiation fluence from, y2Ir and l98Au sources,” Radiology 146, 791–792 (1983).
41. P. Kneschaurek and H. Lindner, “Dose and dose distribution close to Ir sources,” Strahlentherapie 161, 706–710 (1985).
42. J. A. Meli. A. S. Meigooni, and R. Nath, “On the choice of phantom material for the dosimetry of Ir sources,” Int. J. Radiat. Oncol. Biol. Phys. 14, 587–594 (1988).
43. A. S. Meigooni, J. A. Meli, and R. Nath, “Influence of the variation of energy spectra with depth in the dosimetry of Ir using LiF TLD,” Phys. Med. Biol. 33, 1159–1170 (1988).
44. M. T. Gillin, F. Lopez, R. W. Kline, D. F. Grimm, and A. Niroomand-Rad, “Comparison of measured and calculated dose distributions around a l92Ir wire,” Med. Phys. 15, 915–918 (1988).
45. G. Luxton. M. A. Astrahan, P. E. Liggett, D. L. Neblett, D. M. Cohen, and Z. Petrovich. “Dosimetric calculations and measurements of gold plaque ophthalmic irradiators using Ir and 1 seeds,” Int. J. Radiat. Oncol. Biol. Phys. 15, 167, 176 (1988).
46. C. Thomason and P. Higgins, “Radial dose distribution of Ir and l37Cs seed sources,” Med. Phys. 16, 254–257 (1989).
47. J. A. Meli, A. S. Meigooni, and R. Nath, “Comments on radial dose distribution of Ir and Cs seed sources,” Med. Phys. 16, 824 (1989) and reply to comments of Meil, Meigooni, and Nath, p. 825.
48. C. Thomason, T. R. Mackie, M. J. Lindstrom, and P. D. Higgins, “The dose distribution surrounding Ir and Cs seed sources,” Phys. Med. Biol. 36, 475–493 (1991).
49. C. Thomason, T. R. Mackie, and M. J. Lindstrom, “Effect of source encapsulation on the energy spectra of Ir and Cs seed sources,” Phys. Med. Biol. 36, 495–506 (1991).
50. R. Loevinger, “Absorbed dose from interstitial and intracavitary sources,” in DHEW Publication FDA-72-8024 Afterloading in Radiotherapy, Dept. of Health, Education, and Welfare (Rockville, MD, 1972), pp. 192–203.
51. B. S. Hilaris, J. G. Holt, and J.S. Germain, The Use of Iodine-125 for Interstitial Implants, DHEW Publication (FDA) 76–8022 (U.S. Department of Health, Education and Welfare, Rockville, Maryland, 1975).
52. L. L. Anderson, “Dosimetry for Interstitial Brachytherapy,” in Handbook of Interstitial Brachytherapy, edited by B. S. Hilaris (Publishing Science Group, Acton, MA, 1975), pp. 87–115.
53. J. G. Holt, D. J. Perry, and L. E. Reinstein, “The design of an ionization chamber to measure exposure in air for mammographic techniques,” Med. Phys. 2, 172 (1975), Abstract.
54. L. L. Anderson and I. Y. Ding, “Dosimetry considerations for I,” in Afterloading: 20 Years of Experience 7955–75, edited by B. S. Hilaris (Robert Gold and Assoc., New York, 1975), pp. 63–72.
55. V. Krishnaswamy, “Dose distribution around an I seed source in tissue,” Radiology 126, 489–491 (1978).
56. C. C. Ling, L. L. Anderson, and W. U. Shipley, “Dose inhomogeneity in interstitial implants using 1 seeds,” Int. J. Radiat. Oncol. Biol. Phys. 5, 419–425 (1979).
57. 125I activity using solid state detectors,” Med. Phys. 7, 551–554 (1980).
58. 125I using a scintillation detector,” Med. Phys. 7, 355–361 (1980).
59. G. S. Burns and D. E. Raeside, “Monte Carlo simulation on the dose distribution around a commercial I seed,” Med. Phys. 15, 56–60 (1988).
60. C. C. Ling, E. D. Yorke, I. J. Spiro, D. Kubiatowicz, and D. Bennett, “Physical dosimetry of 1 seeds of a new design for interstitial implant,” Int. J. Radiat. Oncol. Biol. Phys. 9, 1747–1752 (1983).
61. G. H. Hartmann, W. Schlegel, and H. Scharfenberg, “The three-dimensional dose distribution of I seeds in tissue,” Phys. Med. Biol. 28, 693–699 (1983).
62. K. A. Weaver, “Response of LiF powder to I photons,” Med. Phys. 11, 850–854 (1984).
63. H. Kubo, “Exposure contribution from Ti K x rays produced in the titanium capsule of the clinical I seed,” Med. Phys. 12, 215–220 (1985).
64. S.-T. Chiu-Tsao, K. O’Brien, R. Sanna, H.-S. Tsao, C. Vialotti, Y. S. Chang, M. Rotman, and S. Packer, “Monte Carlo dosimetry for 1 and Co in eye plaque therapy,” Med. Phys. 13, 678–682 (1986).
65. G. S. Burns and D. E. Raeside, “Two-dimensional dose distribution around l25I seeds,” Med. Phys. 14, 420–424 (1987).
66. J. F. Williamson, “Monte Carlo evaluation of specific dose constants in water for l25I seeds,” Med. Phys. 15, 686–694 (1988).
67. G. Herbold, G. Hartmann, H. Treuer, and W. J. Lorenz, “Monte Carlo calculation of energy buildup factors in the range from 15 to 100 keV, with special reference to the dosimetry of I seeds,” Phys. Med. Biol. 33, 1037–1053 (1988).
68. A. Piermattei, G. Arcovito, andF. Andreasi Bassi“Experimental dosimetry of I new seeds (mod. 6711) for brachytherapy treatments,” Phys. Med. 1. 59–70 1988).
69. A. M. Hashemi, M. D. Mills, K. R. Hogstrom, and P. R. Almond, “The exposure rate constant for a silver wire I seed,” Med. Phys. 15, 228–234 (1988).
70. J. Halbleib, “Structure and operation of the ITS code system,” in Monte Carlo Transport of Electrons and Photons, edited by T. M. Jenkins, W. R. Nelson, and A. Rindi (Plenum, New York, 1988), pp. 249–262.
71. G. Luxton, M. A. Astrahan. D. O. Findley, and Z. Petrovich, “Measurement of dose rate from exposure-calibrated I seeds,” Int. J. Radiat. Oncol. Biol. Phys. 8, 1199–1207 (1990).
72. J. Cygler, J. Szanto, M. Soubra, and D. W. O. Rogers, “Effects of gold and silver backings on the dose rate around an I seed,” Med. Phys. 17, 172–178 (1990).
73. W. R. Nelson and D. W. Rogers, “Structure and operation of the EGS-4 code system,” in Monte Carlo Transport of Electrons and Photons, edited by T. M. Jenkins, W. R. Nelson, and A Rindi (Plenum, New York, 1988), pp. 287–306.
74. G. Luxton, M. A. Astrahan, and Z. Petrovich, “Backscatter measurements from a single seed of 1 for ophthalmic plaque dosimetry,” Med. Phys. 15. 397–400 (1988).
75. K. A. Weaver, “The Dosimetry of I seed eye plaques,” Med. Phys. 13, 73–83 (1986).
76. A. Wu, E. S. Stemick, and D. J. Muse, “Effect of gold shielding on the dosimetry of an 125I seed at close range,” Med. Phys. 15, 627–628 (1988).
77. A. N. Harnett and E. S. Thomson, “An l25I plaque for radiotherapy of the eye: Manufacture and dosimetric calculations,” Br. J. Radiol. 61, 835–838 (1988).
78. S. T. Chiu-Tsao, L. L. Anderson, and I. Stabile, “TLD Dosimetry for I eye plaque,” Phys. Med. Biol. 33 Supp 1 1988) 128 (abstract).
79. J. A. Meli and K. A. Motakabbir, “The effect of lead, gold, and silver backings on dose near l25I seeds,” Med. Phys. A 20, 1251–1256 (1993).
80. G. Luxton, “Comparison of radiation dosimetry in water and in solid phantom materials for 1–125 and Ir-192 brachytherapy sources: EGS4 Monte Carlo study,” Med. Phys. 21, 631–641 (1994).